ATE128122T1 - 9-substituierte bicyclo (3.3.0>octan-derivate verwendbar als txa2-antagonisten. - Google Patents

9-substituierte bicyclo (3.3.0>octan-derivate verwendbar als txa2-antagonisten.

Info

Publication number
ATE128122T1
ATE128122T1 AT92922093T AT92922093T ATE128122T1 AT E128122 T1 ATE128122 T1 AT E128122T1 AT 92922093 T AT92922093 T AT 92922093T AT 92922093 T AT92922093 T AT 92922093T AT E128122 T1 ATE128122 T1 AT E128122T1
Authority
AT
Austria
Prior art keywords
pct
substituted bicyclo
octane derivatives
derivatives usable
txa2 antagonists
Prior art date
Application number
AT92922093T
Other languages
German (de)
English (en)
Inventor
Ulrich Klar
Helmut Vorbrueggen
Hartmut Rehwinkel
Karl-Heinz Thierauch
Peter Verhallen
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of ATE128122T1 publication Critical patent/ATE128122T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/005Analogues or derivatives having the five membered ring replaced by other rings
    • C07C405/0075Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system
    • C07C405/0083Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system which is only ortho or peri condensed, e.g. carbacyclins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT92922093T 1991-10-11 1992-10-09 9-substituierte bicyclo (3.3.0>octan-derivate verwendbar als txa2-antagonisten. ATE128122T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4134156A DE4134156A1 (de) 1991-10-11 1991-10-11 9-substituierte bicyclo(3.3.0)octan-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung

Publications (1)

Publication Number Publication Date
ATE128122T1 true ATE128122T1 (de) 1995-10-15

Family

ID=6442746

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92922093T ATE128122T1 (de) 1991-10-11 1992-10-09 9-substituierte bicyclo (3.3.0>octan-derivate verwendbar als txa2-antagonisten.

Country Status (8)

Country Link
US (1) US5405988A (fr)
EP (1) EP0563358B1 (fr)
JP (1) JPH06505506A (fr)
AT (1) ATE128122T1 (fr)
CA (1) CA2097930A1 (fr)
DE (2) DE4134156A1 (fr)
PT (1) PT100950A (fr)
WO (1) WO1993007118A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001296536A1 (en) * 2000-10-03 2002-04-15 University Of Virginian Patent Foundation Novel lysophosphatidic acid receptor agonists and antagonists
EP1383778B1 (fr) 2001-01-30 2009-10-21 University Of Virginia Patent Foundation Agonistes et antagonistes de recepteurs de sphingosine-1-phosphate
CA2533587A1 (fr) * 2002-07-30 2004-02-05 University Of Virginia Patent Foundation Composes actifs dans la signalisation de sphingosine 1-phosphate
US7638637B2 (en) * 2003-11-03 2009-12-29 University Of Virginia Patent Foundation Orally available sphingosine 1-phosphate receptor agonists and antagonists
EP1750722A4 (fr) * 2004-05-06 2010-03-10 Univ Virginia Nouveaux antagonistes selectifs du recepteur de l'acide lysophosphatidique
MX2007006706A (es) * 2004-12-06 2007-10-18 Univ Virginia Analogos de esfingosina 1-fosfato amida de arilo.
WO2006088944A1 (fr) 2005-02-14 2006-08-24 University Of Virginia Patent Foundation Agonistes de sphingosine-1-phosphate comportant des cycloalcanes et heterocycles substitues par des groupes amino et phenyle
RU2008134702A (ru) * 2006-01-27 2010-03-10 Юниверсити Оф Вирждиния Пэтент Фаундейшн (Us) Способ лечения невропатической боли
WO2007092638A1 (fr) * 2006-02-09 2007-08-16 University Of Virginia Patent Foundation Analogues de sphingosine 1-phosphate bicyclique
JP2010510249A (ja) * 2006-11-21 2010-04-02 ユニバーシティ オブ バージニア パテント ファンデーション スフィンゴシン=1−燐酸アゴニスト活性を有するテトラリンアナログ
WO2008064337A2 (fr) * 2006-11-21 2008-05-29 University Of Virginia Patent Foundation Analogues benzocycloheptyle ayant une activité de récepteur de sphingosine 1-phosphate
EP2099741A2 (fr) * 2006-11-21 2009-09-16 University Of Virginia Patent Foundation Analogues d'hydrindane ayant une activité agoniste de récepteur de sphingosine-1-phosphate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588823A (en) * 1982-02-16 1986-05-13 The Upjohn Company 9-substituted carbacyclin analogs
US4487961A (en) * 1982-02-16 1984-12-11 The Upjohn Company 9-Substituted carbacyclin analogs
DE3428266A1 (de) * 1984-07-27 1986-01-30 Schering AG, 1000 Berlin und 4709 Bergkamen Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4971987A (en) * 1984-07-27 1990-11-20 Schering Aktiengesellschaft New carbacycline, process for their production and their use as a drug
DE3542745A1 (de) * 1985-11-29 1987-08-06 Schering Ag Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3725031A1 (de) * 1987-07-24 1989-02-02 Schering Ag Neue 9-substituierte carbacyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
US5405988A (en) 1995-04-11
EP0563358A1 (fr) 1993-10-06
PT100950A (pt) 1993-11-30
CA2097930A1 (fr) 1993-04-12
DE4134156A1 (de) 1993-04-15
WO1993007118A1 (fr) 1993-04-15
DE59203771D1 (de) 1995-10-26
JPH06505506A (ja) 1994-06-23
EP0563358B1 (fr) 1995-09-20

Similar Documents

Publication Publication Date Title
FR2800375B1 (fr) Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant
MX9203053A (es) Derivados de aza nor bornano.
FI942187A0 (fi) Asyklisiä etyleenidiamiinijohdannaisia aine P-reseptoriantagonisteina
RU94027577A (ru) Производные 1-бензолсульфонил-1,3-дигидро-2н-бензимидазол-2-она, способ их получения, содержащая их фармацевтическая композиция
ATE316083T1 (de) Adamantanderivate
ATE128122T1 (de) 9-substituierte bicyclo (3.3.0>octan-derivate verwendbar als txa2-antagonisten.
FR2804115B1 (fr) Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant
MXPA02009643A (es) Sintesis acortada de derivados de 3,3-diarilpropilamina.
DE59610175D1 (de) Hydantoinderivate als zwischenprodukte für pharmazeutische wirkstoffe
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
NO950177L (no) Farmakologisk aktive erivater
AU667294B2 (en) Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals
ATE128966T1 (de) Bicyclo (3.3.0>octan-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
ATE72236T1 (de) Neue 9-substituierte carbacyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
AU1459192A (en) Aminoacyl derivatives of gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them
GR3021761T3 (en) Leukotriene-b 4? derivatives, process for preparing the same and medicaments.
ES2095058T3 (es) Derivados del 3-azabiciclo(3.2.0)heptano substituidos como productos intermedios.
ES2101531T3 (es) Derivados de benzo(f)quinoxalinadiona, su preparacion y su utilizacion en medicamentos.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee